Description
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
LH846 is an inhibitor of casein kinase 1δ (CK1δ) that also displays activity against CK1α and CK1ε. In research models, this compound lengthens the circadian period.
Cas No. | 639052-78-1 |
---|---|
Purity | ≥98% |
Formula | C16H13ClN2OS |
Formula Wt. | 316.80 |
IUPAC Name | N-(5-Chloro-6-methyl-1,3-benzothiazol-2-yl)-2-phenylacetamide |
Solubility | 100mM in DMSO |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Lee JW, Hirota T, Peters EC, et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein. Angew Chem Int Ed Engl. 2011 Nov 4;50(45):10608-11. PMID: 21954091.
Macrocyclic lactone.
Fibrate; PPARα agonist.
SIRT1/2 inhibitor, indirect p53 activator.
Diterpene found in roasted coffee.
Hormonal attractant for male Bactrocera flies.<...
STING inhibitor
EGFR, VEGFR inhibitor.
NSAID; COX-2 inhibitor.
Dihydropyridine; L-type Ca2+ channel blocker.
β2-adrenergic agonist.
Peptide, derivative of AT I, cleavage product o...
5-α-Reductase inhibitor.
Proteasome inhibitor, miR33b modulator.
Cephalosporin analogue
Arylbenzimidazole; CHK2 inhibitor.
Peptide; FRP1 antagonist.
Lipopeptide; 1,3-β-Glucan synthase inhibitor.<...
Inhibitor of EGFR.
Induces cardiomyogenic effects in pluripotent c...
NSAID; COX-2 inhibitor.